Table 1. Characteristics of the studies included in the meta-analysis.
Polymorphism | Reference | Year | Country | Ethnicity | Disease type | Control source | Case | Control | Smoking (%) | Genotyping method | P# value | NOS score | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CC | CT | TT | CC | CT | TT | Case | Control | ||||||||||
MMP-9-1562 C/T | de Souza | 2005 | Brazil | Mixed | CP | HB | 42 | 20 | 0 | 24 | 13 | 1 | 0 | 0 | PCR-RFLP | 0.62 | 7 |
Holla | 2006 | Czech | Caucasian | CP | HB | 122 | 43 | 4 | 93 | 37 | 5 | 26.0 | 29.6 | PCR | 0.59 | 8 | |
Keles | 2006 | Turkish | Caucasian | CP | HB | 57 | 13 | 0 | 42 | 24 | 4 | NA | NA | PCR | 0.82 | 7 | |
Chen | 2007 | China | Asian | AgP | PB | 62 | 15 | 2 | 101 | 26 | 1 | NA | NA | PCR-RFLP | 0.63 | 7 | |
Gurkan | 2007 | Turkish | Caucasian | AgP | HB | 58 | 53 | 1 | 78 | 72 | 7 | 32.6 | 5.1 | PCR | 0.06 | 7 | |
Gurkan | 2008 | Turkish | Caucasian | CP | PB | 54 | 32 | 1 | 52 | 52 | 3 | 47.1 | 3.7 | PCR | 0.02 | 6 | |
Loo | 2011 | China | Asian | CP | PB | 143 | 73 | 64 | 43 | 72 | 135 | NA | NA | PCR-RFLP | <0.01 | 6 | |
Isaza-Guzman | 2011 | Colombia | Mixed | CP | HB | 58 | 11 | 0 | 47 | 6 | 1 | 14.6 | 4.9 | PCR-RFLP | 0.16 | 7 | |
Li | 2012 | China | Asian | CP | PB | 68 | 26 | 28 | 99 | 156 | 277 | 93.4 | 97.7 | PCR-RFLP | <0.01 | 6 | |
MMP-3-1171 A5/A6 | A5/A5 | A5/A6 | A6/A6 | A5/A5 | A5/A6 | A6/A6 | |||||||||||
Itagaki | 2004 | Japan | Asian | AgP | HB | 0 | 17 | 20 | 4 | 38 | 100 | NA | NA | Taqman | 0.87 | 8 | |
Itagaki | 2004 | Japan | Asian | CP | HB | 5 | 58 | 142 | 4 | 38 | 100 | NA | NA | Taqman | 0.87 | 8 | |
Astolfi | 2006 | Brazil | Mixed | CP | PB | 19 | 52 | 19 | 8 | 70 | 25 | NA | NA | PCR-RFLP | <0.01 | 6 | |
Loo | 2011 | China | Asian | CP | PB | 154 | 115 | 11 | 100 | 135 | 15 | NA | NA | PCR-RFLP | <0.01 | 6 | |
Li | 2012 | China | Asian | CP | PB | 75 | 44 | 3 | 213 | 283 | 36 | 93.4 | 97.7 | PCR-RFLP | <0.01 | 6 | |
Letra* | 2012 | Brazil | Mixed | CP | HB | NA | NA | NA | 121 | 114 | 64 | NA | NA | Taqman | <0.01 | 6 | |
Letra* | 2012 | US | Caucasian | CP | HB | NA | NA | NA | 51 | 91 | 62 | NA | NA | Taqman | 0.13 | 7 | |
MMP-8-799C/T | CC | CT | TT | CC | CT | TT | |||||||||||
Chou | 2011 | China | Asian | CP | PB | 122 | 191 | 48 | 53 | 40 | 13 | 25.5 | 15.1 | PCR-RFLP | 0.22 | 8 | |
Chou | 2011 | China | Asian | AgP | PB | 34 | 50 | 12 | 53 | 40 | 13 | 25 | 15.1 | PCR-RFLP | 0.22 | 7 | |
Holla | 2012 | Czech | Caucasian | CP | HB | 88 | 163 | 90 | 84 | 134 | 60 | 30 | 28 | PCR-RFLP | 0.63 | 8 | |
Emingil | 2014 | Turkey | Caucasian | AgP | PB | 11 | 57 | 32 | 76 | 66 | 25 | 29 | 3.6 | TaqMan | 0.10 | 8 | |
MMP-2-753C/T | CC | CT | TT | CC | CT | TT | |||||||||||
Holla | 2005 | Czech | Caucasian | CP | PB | 107 | 38 | 4 | 93 | 30 | 4 | NA | NA | PCR-RFLP | 0.42 | 8 | |
Chen | 2007 | China | Asian | AgP | PB | 63 | 15 | 1 | 98 | 28 | 2 | NA | NA | PCR-RFLP | 1.00 | 7 | |
Gurkan | 2007 | Turkish | Caucasian | AgP | HB | 49 | 39 | 4 | 98 | 54 | 5 | 32.6 | 5.1 | PCR | 0.06 | 7 | |
Gurkan | 2008 | Turkish | Caucasian | CP | PB | 51 | 32 | 4 | 67 | 37 | 3 | 47.1 | 3.7 | PCR | 0.43 | 6 |
CP = chronic periodontitis, AgP = aggressive periodontitis, NA = not available, HB = hospital-based, PB = population-based.
P# for Hardy-Weinberg equilibrium, *Only allele number available in controls.